Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592982 · ClinicalTrials.gov registry record
Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging
A clinical trial of Bisphosphonate-associated ONJ and Osteomyelitis of the Jaw, sponsored by University of Arkansas.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT00592982: Completed study of Bisphosphonate-associated ONJ and Osteomyelitis of the Jaw, sponsored by University of Arkansas.
NCT00592982 is a study of Bisphosphonate-associated ONJ and Osteomyelitis of the Jaw that has completed, run by University of Arkansas. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592982, a study of Bisphosphonate-associated ONJ and Osteomyelitis of the Jaw, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
1. Bisphosphonate-associated osteonecrosis of the jaw(ONJ)is detectable by positron emission tomography(PET). 2. Bisphosphonate-associated ONJ can be diagnosed and characteristically differentiated from other bony pathologies of the jaw(osteomyelitis, osteolytic lesions, and osteoradionecrosis)by PET imaging.
Conditions Studied
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-10 |
| Est. Completion | 2013-08 |
What the finished NCT00592982 record still lists
NCT00592982 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 4 conditions, with Bisphosphonate-associated ONJ appearing as the primary indexed condition, and to 0 interventions.
NCT00592982 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT00592982 about?
NCT00592982 is a clinical study titled "Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging". 1. Bisphosphonate-associated osteonecrosis of the jaw(ONJ)is detectable by positron emission tomography(PET). 2. Bisphosphonate-associated ONJ can be diagnosed and characteristically differentiated from other bony pathologies of the jaw(osteomyelitis, osteolytic lesions, and osteoradionecrosis)by PE...
What is the current status of trial NCT00592982?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2006-10. Estimated completion is 2013-08.
What conditions does trial NCT00592982 study?
This clinical trial studies the following conditions: Bisphosphonate-associated ONJ, Osteomyelitis of the Jaw, Osteolytic Lesions of the Jaw, Osteoradionecrosis of the Jaw.
Who is sponsoring clinical trial NCT00592982?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00592982 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia